David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Meta Platforms (Facebook)
META
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
T-Mobile US
TMUS
|
+$416M |
| 5 |
Uber
UBER
|
+$350M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$547M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$490M |
| 3 |
Johnson & Johnson
JNJ
|
+$444M |
| 4 |
Apple
AAPL
|
+$435M |
| 5 |
Accenture
ACN
|
+$378M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.7% |
| 2 | Consumer Discretionary | 8.8% |
| 3 | Healthcare | 8.52% |
| 4 | Financials | 6% |
| 5 | Industrials | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Horizon Bancorp
HBNC
$1.01B
| $275K | ﹤0.01% |
26,451
+9,180
| +53% | +$91.1K |
|
|
NVO
3502
CALL
Novo Nordisk
NVO
$207B
| $275K | ﹤0.01% |
+3,400
| New | +$278K |
|
|
HLTH
3503
DELISTED
Cue Health Inc. Common Stock
HLTH
| $275K | ﹤0.01% |
744,739
+350,604
| +89% | +$299K |
|
|
GORV
3504
DELISTED
Lazydays
GORV
| $275K | ﹤0.01% |
792
+264
| +50% | +$90.6K |
|
|
FL
3505
DELISTED
Foot Locker
FL
| $274K | ﹤0.01% |
10,125
+1,125
| +13% | +$38.3K |
|
3506
Blackstone Mortgage Trust
BXMT
$2.38B
| $274K | ﹤0.01% |
13,187
-33,468
| -72% | -$615K |
|
3507
ATN International
ATNI
$477M
| $274K | ﹤0.01% |
7,490
-100
| -1% | -$3.84K |
|
3508
Organon & Co
OGN
$3.61B
| $274K | ﹤0.01% |
+13,150
| New | +$286K |
|
3509
CALL
Teva Pharmaceuticals
TEVA
$43B
| $273K | ﹤0.01% |
36,300
| – | – |
|
|
PNNT
3510
Pennant Park Investment Corp
PNNT
$246M
| $273K | ﹤0.01% |
46,365
-81,252
| -64% | -$439K |
|
3511
Atossa Therapeutics
ATOS
$26.3M
| $273K | ﹤0.01% |
14,435
-40,456
| -74% | -$491K |
|
|
HLLY.WS
3512
DELISTED
Holley Inc Warrants
HLLY.WS
| $272K | ﹤0.01% |
542,429
+201,667
| +59% | +$72.5K |
|
3513
NetEase
NTES
$78.7B
| $271K | ﹤0.01% |
+2,800
| New | +$253K |
|
3514
Northeast Bank
NBN
$1.11B
| $268K | ﹤0.01% |
6,434
-11,116
| -63% | -$422K |
|
|
AMRN
3515
Amarin Corp
AMRN
$292M
| $267K | ﹤0.01% |
11,213
-9,321
| -45% | -$239K |
|
3516
Oil States International
OIS
$501M
| $266K | ﹤0.01% |
35,664
-9,894
| -22% | -$72.2K |
|
3517
Utah Medical Products
UTMD
$228M
| $264K | ﹤0.01% |
2,830
+442
| +19% | +$41.6K |
|
3518
Avista
AVA
$3.18B
| $263K | ﹤0.01% |
6,700
-77,596
| -92% | -$3.29M |
|
3519
Lumentum
LITE
$74.5B
| $263K | ﹤0.01% |
4,636
-79,474
| -94% | -$3.97M |
|
|
SLGC
3520
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $262K | ﹤0.01% |
113,248
-93,859
| -45% | -$265K |
|
3521
Drilling Tools International
DTI
$88.6M
| $262K | ﹤0.01% |
60,000
-830,957
| -93% | -$7.14M |
|
3522
Asbury Automotive
ABG
$3.79B
| $261K | ﹤0.01% |
1,087
-23,946
| -96% | -$5.03M |
|
3523
CALL
Fiverr
FVRR
$337M
| $260K | ﹤0.01% |
10,000
| – | – |
|
3524
QCR Holdings
QCRH
$1.65B
| $260K | ﹤0.01% |
6,339
-1,378
| -18% | -$56.4K |
|
3525
Movado Group
MOV
$772M
| $258K | ﹤0.01% |
+9,623
| New | +$252K |
|
Similar funds
David Shaw's Q2 2023 Portfolio in Review
As of Q2 2023, David Shaw held 4,841 positions worth $97.9B, up 4.8% from $93.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $4.46B in Q2 2023, closing 639 positions and reducing 1,586 holdings. Its most notable exit was Shaw Communications Inc., an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, David Shaw opened a new position in Oracle worth $217M.
- David Shaw's largest Q2 2023 buy was Oracle: 1,825,762 shares worth $217M.
- David Shaw added most to NVIDIA in Q2 2023, an estimated $997M increase.
- David Shaw's biggest Q2 2023 reduction was Visa, cutting an estimated $547M.
- David Shaw fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $152M.
- David Shaw's ten largest holdings make up 12% of its $97.9B portfolio in Q2 2023.
- David Shaw opened 467 new positions and closed 639 in Q2 2023.
- David Shaw's portfolio value rose 4.8% quarter-over-quarter to $97.9B.
Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.